Heart-rate Variability and Disability Status in Multiple Sclerosis: Is There a Link?
A new study suggests the correlation of heart rate variability with disease disability in multiple sclerosis patients as autonomic dysfunction is common in such patients. The study evaluated the feasibility of heart rate variability as a measure of autonomic dysfunction using wearable sensors and its association with clinical measures of disease activity in 29 multiple […]
Ocrelizumab in Relapsing-Remitting and Progressive Multiple Sclerosis
Ocrelizumab was found to be effective and safe therapy in relapsing-remitting, primary-progressive and secondary-progressive multiple sclerosis patients. Performed on 153 patients (mean age: 41.9 years; 60% females; mean EDSS: 3.5), this study provided first real-world effectiveness and safety data and the possible predictors of treatment response. After 2 years, percentage disability worsening-free patients were 90.5%, […]
Thyroid Diseases and Restless Legs Syndrome in Multiple Sclerosis Patients
Name – 7th Congress of the European Academy of Neurology (June 19 – June 22, 2021) Mode – Virtual A study concluding that multiple sclerosis patients with thyroid disorder are at higher risk for restless leg syndrome, was presented at 7th Congress of the European Academy of Neurology. Multiple sclerosis, a chronic autoimmune disease, has […]
Biomarkers of Primary Progressive Multiple Sclerosis
Name – 7th Congress of the European Academy of Neurology (June 19 – June 22, 2021) Mode – Virtual CXCL12 and Osteopontin were found to be biomarkers of multiple sclerosis progression as per the new research presented at 7th Congress of the European Academy of Neurology. Primary progressive multiple sclerosis involves degenerative and inflammatory processes […]
Multiple Sclerosis to Have Milder COVID-19 Symptoms?
A cross-sectional study conducted on 543 Multiple Sclerosis patients suggested that most Multiple Sclerosis patients developed a mild course of COVID-19 infection. The study was conducted to identify suspected COVID-19 cases and associated factors in Multiple Sclerosis patients by interrogation over phone and evaluating the medical records. Common symptoms suspicious for COVID-19 infection included dyspnea, […]